Hyperlipidemia and Lipid Types PDF

Summary

This document provides an overview of hyperlipidemia and different types of lipids, specifically cholesterol and lipoproteins (LDL, VLDL, HDL). It explains their roles in the body and potential health risks.

Full Transcript

**Hyperlipidemia and Lipid Types** **Hyperlipidemia:** - A condition characterized by high levels of lipids (fats) in the blood, including cholesterol and triglycerides - Associated with increased risk of atherosclerosis, coronary artery disease (CAD), thrombosis, CVA, pancreatitis (f...

**Hyperlipidemia and Lipid Types** **Hyperlipidemia:** - A condition characterized by high levels of lipids (fats) in the blood, including cholesterol and triglycerides - Associated with increased risk of atherosclerosis, coronary artery disease (CAD), thrombosis, CVA, pancreatitis (from triglycerides) - Increased risk of atherosclerotic cardiovascular disease = **ASCVD** risk **Cholesterol** A waxy substance found in your blood, necessary for building cell membranes and the synthesis of certain hormones but harmful in excess **Lipoprotein** **Families of Lipoproteins** 1. **LDL (Low-Density Lipoprotein)** - Major cholesterol carrier (2/3 -- ¾ is carried by LDL) - Delivers cholesterol to non-hepatic tissues - Often called \"bad\" cholesterol - Can build up in the walls of your arteries and form plaques, leading to atherosclerosis - The risk of developing CAD is directly related to increased LDL 1. **VLDL (Very Low-Density Lipoprotein)** - Another type of \"bad\" cholesterol - Carries triglycerides from liver to adipose tissue and muscle - Can also contribute to plaque buildup - Triglycerides are the main component - Majority stored in tissue as glycerol fatty acids 2. **HDL(High-Density Lipoprotein)** - Known as \"good\" cholesterol - Helps remove other forms of cholesterol from your bloodstream - Carries 1/3 to ¼ of cholesterol **Total cholesterol: \ - Drug not absorbed systemically, so side effects r/t GI tract - Constipation, bloating, flatulence - Pruritus - Fecel impaction, intestinal obstruction: will need to prescribe stool softener or fiber supplement (Metamucil) - Implications: - Encourage high fiber foods (whole grains cereals, fruits/veggies) - Mix powder into moist foods - Increase fluids (encourage 6-8 oz of fluid) - Because these are resin exchange: - Increase chance for meds & vitamins to bind if taken within 4 hours of the resin - Take meds 1 hr before or 4 hrs after - Can decrease folate levels: supplement in young women and children - **Examples: Cholestyramine, Colestipol, Colesevelam** 2. **HMG-CoA Reductase Inhibitors (Statins)**: Inhibit the enzyme HMG-CoA reductase, reducing cholesterol synthesis in the liver - This depletes intracellular cholesterol - The cell then looks to the extracellular space for the cholesterol it needs - Result is lowering of plasma cholesterol and LDL levels - Absorption & Distribution: High first-pass effect, Highly protein bound - Metabolism & Excretion: metabolized by the live, excreted primarily in the feces, 10% eleminted in the urine - IR forms best absorbed after meals - ER forms are impaired by food - **Examples: Lovastatin, Pravastatin, Atorvastatin, Simvastatin, Fluvastatin, Rosuvastatin (Rosuvastatin is a 2^nd^ generation statin)** 3. **Fibric Acid Derivatives (Fibrates)**: Reduce triglycerides by increasing the enzyme lipoprotein lipase (which breaks down cholesterol) - Reduce triglycerides by 35-53% - Raise HDL levels by 15-25% - Effect on LDL lower by 6-20% (or raise slightly) - Used in combination with statins for those with severe increased TG levels (TG \500) - **Usually prescribed for those with hypertriglyceridemia severe enough to increase the risk of pancreatitis** - Tend to concentrate bile in the gallbladder leading to increase risk for cholelithiasis (gall stones) - Contraindicated in patients who already has preexisting gall bladder disease or hepatic dysfunction - These drugs are teratogenic in animal studies - Adverse Effects: - Abdominal pain and diarrhea - cholelithiasis - Liver tumors - Implications - Monitor lab testing including LFTs - Monitor for signs of cholelithiasis - Intolerance to fatty foods - Nausea/vomiting - RUQ abd pain - Clay-colored stool - Low grade fever - Drug Interactions: - May potentiate effects of oral anticoagulants - **Gemfibrozil- inhibits metabolism of most statins (increasing risk of myopathy & rhabdo)\*\*\*** - **Examples: Gemfibrozil, Fenofibrate, Clofibrate** 4. **Nicotinic Acid (Niacin- Vitamin B3)**: MOA on lipid levels unknown, but thought that it inhibits lipolysis in adipose tissue - Decreases circulating fibrinogen levels and increases tissue plasminogen: end result is a decrease risk of thrombosis formation - Triglycerides and VLDL levels reduced by 25-35% in 1-4 days - LDL reduction in 5-7 days - HDL increases 15-35% (better than any other drug) - Used in treating high triglyceride levels - Dose of niacin needed to treat hyperlipidemia is a much higher dose than is used to treat niacin deficiency - As a vitamin the dose is 25mg - A dose of 2000-3000mg is needed to decrease LDL - Doses of 1200-1500 mg/day needed to decrease TG and increase HDL - Adverse Effects (many due to high required dose) - Intolerable to many patients and leads to non-compliance - Peripheral vasodilation and transient flushing (d/t histamine release and mediated thru prostaglandins- recommended patients take 325mg ASA tablet or 200mg Ibuprofen 30 min prior to decrease symptoms - GI irritation - Myalgias (muscle pain) when combined with statins - **Hepatotoxicity: exclusively with sustained release products of doses \1500mg** - Sustained release products are classified as a dietary supplement (not monitored by FDA) - Nicotinamide (OTC Niacin) has no lipid lowering effect - Usually not prescribed in diabetics d/t increase blood sugar levels - Rapidly absorbed in the intestine 5. **Cholesterol Absorption Inhibitors**: Inhibit (block) the absorption of dietary cholesterol in the small intestine and biliary cholesterol without working through the bile acids - Acts on brush border of small intestine - Decreases hepatic cholesterol stores - Decrease LDL by 17% - Newest on the market - Does not affect triglycerides or HDL - Given once daily (monotherapy or combination with statins) - Clinical trials showed no improvement outcomes in CAD and actually worsened artery wall thickness - Use as a last resort - Precautions & Contraindications: - Active liver disease - Persistently elevated liver enzymes - Restricted to children 10 years or older - Adverse Effects: - Abdominal pain - Diarrhea (severe) - Back pain - Sinusitis - Associated with skeletal defects in animal studies - **Example: Zetia, Ezetimibe** **\ ** **Benefits of Statin Therapy** \*LDL cholesterol by 20-60% \*Raising HDL by 5-10%, \*Lowers Triglycerides 10-33%: Additional benefits of statin therapy: - Stabilize plaque in blood vessels - Statins have anti-inflammatory effects- CRP levels will fall with statin therapy - Decrease thrombogenicity of blood (decreasing clot formation) - stabilize plaques in arteries - reduce the risk of heart attack and stroke (Simvastatin, Atorvastatin, Rosuvastatin) - block vasoconstrictive effects of the amyloid-beta protein (protein associated with Alzheimer') - may be protective against dementia caused by blood vessel vasoconstriction - ? ability to lower incidence of colorectal cancer **Side Effects of Statins (more serious side effects seen with use of Rosuvastatin- crestor)** Common side effects include: - Non-specific aches and muscle pain - Elevated LFT's (hepatotoxicity) - Increased blood sugar levels (new onset diabetes rare) - Rarely, they can cause severe muscle damage (rhabdomyolysis) **ACC/AHA Statin Safety Recommendations** - Selection of statin based on patient characteristics, level of ASCVD risk, & potential for adverse effects - Predisposing characteristics of serious adverse effects: - Multiple comorbidities - H/O previous statin intolerance or muscle disorders - Unexplained ALT elevation \>3 X upper limits of normal - \>75 y/o - Grapefruit juice (limes and tangelos) can inhibit metabolism of statins - This effect can persist up to 3 days after ingestion of the juice - How much juice needs to be consumed: varies, but approx. 8oz will do it - Baseline measurement of ALT should be performed before initiating therapy and during therapy if symptoms of hepatotoxicity arise - Evaluate for new-onset diabetes according to current diabetes screening - May be harmful to initiate Simvastatin at 80mg daily or increase the dose to 80mg daily - Management Algorithm for muscle symptoms - Prior to initiating obtain a history of prior or current muscle symptoms - Development of severe muscle symptoms or fatigue during statin therapy: - Promptly D/C statin - Obtain CK, creatinine and urinalysis for myoglobinuria - Development of mild to moderate muscle symptoms: - D/C statin until symptoms can be evaluated - Evaluate patient for conditions that might increase risk for muscle symptoms - If symptoms resolve: - Give original or lower dose of the same statin to establish causal relationship - If relationship exists: D/C original statin and use lower dose of a different statin - If after 2 months, symptoms persist or CK levels don't resolve, look for other causes (if other causes, restart statin at original dose) **Rhabdomyolysis, Myopathy, and Muscle Aches** - **Rhabdomyolysis (\

Use Quizgecko on...
Browser
Browser